retatrutide trial news Looking forward to when #retatrutide's Phase 3 results will become available. There are are 4 planned TRIUMPH trials investigating retatrutide's efficacy in treating obesity and its complications: #type2diabetes #cardiovascular disease New Phase 3 retatrutide data

In peer-reviewed research these medications, in combination with lifestyle change, are one of the most effective ways to get to a healthier weight

1998;352(9131):837-853 8 Stephen Bloom et.al

The System is Not Set Up for On-Time, Personalized Support Patients starting GLP-1 therapy should be well aware that side effects are possibleas their provider should educate them that these are powerful medications and side effects are common during dose titration

A healthcare provider can help determine the safest option for you regarding weight loss medications and create a personalized plan for your weight loss journey

This was known as the TRIUMPH-1 trial and evaluated 2,339 participants over 80 to 104 weeks

Once-weekly semaglutide doubles the five-year risk of nonarteritic anterior ischemic optic neuropathy in a Danish cohort of 424,152 persons with type 2 diabetes